These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15520195)

  • 1. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T; Itahana Y; Hamakawa H; Desprez PY
    Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment.
    Yoshimura T; Sumida T; Liu S; Onishi A; Shintani S; Desprez PY; Hamakawa H
    Endocr Relat Cancer; 2007 Dec; 14(4):1107-16. PubMed ID: 18045962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
    Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
    Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells.
    Itahana Y; Singh J; Sumida T; Coppe JP; Parrinello S; Bennington JL; Desprez PY
    Cancer Res; 2003 Nov; 63(21):7098-105. PubMed ID: 14612502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells.
    Kattan Z; Minig V; Leroy P; Dauça M; Becuwe P
    Breast Cancer Res Treat; 2008 Mar; 108(2):203-15. PubMed ID: 17473980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line].
    Hou YF; Yuan ST; Li HC; Wu J; Lu JS; Lu LJ; Liu G; Shen ZZ; Ding J; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):389-92. PubMed ID: 16188119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
    Mizuma M; Katayose Y; Yamamoto K; Shiraso S; Sasaki T; Yabuuchi S; Oda A; Masuda K; Rikiyama T; Onogawa T; Ohtsuka H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2008; 28(5A):2669-77. PubMed ID: 19035293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERbeta exerts multiple stimulative effects on human breast carcinoma cells.
    Hou YF; Yuan ST; Li HC; Wu J; Lu JS; Liu G; Lu LJ; Shen ZZ; Ding J; Shao ZM
    Oncogene; 2004 Jul; 23(34):5799-806. PubMed ID: 15208676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
    Dai D; Kumar NS; Wolf DM; Leslie KK
    Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
    Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
    Lin VC; Aw SE; Ng EH; Ng EH; Tan MG
    Br J Cancer; 2001 Dec; 85(12):1978-86. PubMed ID: 11747343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
    Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
    Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
    Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
    Singh J; Murata K; Itahana Y; Desprez PY
    Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.
    Jin R; Bay BH; Chow VT; Tan PH; Lin VC
    Br J Cancer; 2000 Aug; 83(3):319-23. PubMed ID: 10917545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.